82 related articles for article (PubMed ID: 2565017)
1. Preparation and utility of a radioiodinated analogue of daunomycin in the study of multidrug resistance.
Busche R; Tümmler B; Riordan JR; Cano-Gauci DF
Mol Pharmacol; 1989 Apr; 35(4):414-21. PubMed ID: 2565017
[TBL] [Abstract][Full Text] [Related]
2. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
Friche E; Demant EJ; Sehested M; Nissen NI
Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
[TBL] [Abstract][Full Text] [Related]
3. Equilibrium, kinetic and photoaffinity labeling studies of daunomycin binding to P-glycoprotein-containing membranes of multidrug-resistant Chinese hamster ovary cells.
Busche R; Tümmler B; Cano-Gauci DF; Riordan JR
Eur J Biochem; 1989 Jul; 183(1):189-97. PubMed ID: 2568928
[TBL] [Abstract][Full Text] [Related]
4. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
Akiyama S; Yoshimura A; Kikuchi H; Sumizawa T; Kuwano M; Tahara Y
Mol Pharmacol; 1989 Nov; 36(5):730-5. PubMed ID: 2573823
[TBL] [Abstract][Full Text] [Related]
5. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
Klohs WD; Steinkampf RW; Havlick MJ; Jackson RC
Cancer Res; 1986 Sep; 46(9):4352-6. PubMed ID: 3460695
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a K562 multidrug-resistant cell line.
Yanovich S; Hall RE; Gewirtz DA
Cancer Res; 1989 Aug; 49(16):4499-503. PubMed ID: 2568171
[TBL] [Abstract][Full Text] [Related]
7. N-benzyladriamycin-14-valerate (AD 198)-resistant cells exhibit highly selective cross-resistance to other anthracyclines that circumvent multidrug resistance.
Lothstein L; Hosey LM; Sweatman TW; Koseki Y; Dockter M; Priebe W
Oncol Res; 1993; 5(6-7):229-34. PubMed ID: 7907237
[TBL] [Abstract][Full Text] [Related]
8. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
[TBL] [Abstract][Full Text] [Related]
9. B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein.
Borchers C; Ulrich WR; Klemm K; Ise W; Gekeler V; Haas S; Schödl A; Conrad J; Przybylski M; Boer R
Mol Pharmacol; 1995 Jul; 48(1):21-9. PubMed ID: 7623771
[TBL] [Abstract][Full Text] [Related]
10. Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein.
Kartner N; Shales M; Riordan JR; Ling V
Cancer Res; 1983 Sep; 43(9):4413-9. PubMed ID: 6135505
[TBL] [Abstract][Full Text] [Related]
11. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
Nare B; Prichard RK; Georges E
Mol Pharmacol; 1994 Jun; 45(6):1145-52. PubMed ID: 7912815
[TBL] [Abstract][Full Text] [Related]
12. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog.
Akiyama S; Cornwell MM; Kuwano M; Pastan I; Gottesman MM
Mol Pharmacol; 1988 Feb; 33(2):144-7. PubMed ID: 2893251
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression.
Harker WG; Slade DL; Dalton WS; Meltzer PS; Trent JM
Cancer Res; 1989 Aug; 49(16):4542-9. PubMed ID: 2568172
[TBL] [Abstract][Full Text] [Related]
14. Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein.
Foxwell BM; Mackie A; Ling V; Ryffel B
Mol Pharmacol; 1989 Oct; 36(4):543-6. PubMed ID: 2572960
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D
J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM
Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells.
Bogush T; Robert J
Anticancer Res; 1996; 16(1):365-8. PubMed ID: 8615637
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells.
Ouar Z; Bens M; Vignes C; Paulais M; Pringel C; Fleury J; Cluzeaud F; Lacave R; Vandewalle A
Biochem J; 2003 Feb; 370(Pt 1):185-93. PubMed ID: 12435274
[TBL] [Abstract][Full Text] [Related]
19. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
Yusa K; Tsuruo T
Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
[TBL] [Abstract][Full Text] [Related]
20. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
Willingham MC; Cornwell MM; Cardarelli CO; Gottesman MM; Pastan I
Cancer Res; 1986 Nov; 46(11):5941-6. PubMed ID: 3756931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
